| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | See Remarks | Former Executive Officer +2 more
2 companies
Berkman Charles S is a Chief Legal Officer at OABI, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 22 sales. Those positions are worth an estimated $8.5M at current prices.
Our model assigns Berkman Charles S a strong insider score of 81/100, based on 8 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +47.9%.
Berkman Charles S's largest disclosed position is in LGND as Former Executive Officer, worth about $6.8M. The recent filings there lean toward selling, a net 117,496 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | LGND Ligand Pharmaceuticals Inc | SVP, Gen. Counsel &Secretary | Sale+OE | 19,417 | $254.99 | $4,951,065.10 | -41.2% | |
| Aug 9, 2017 | LGND Ligand Pharmaceuticals Inc | VP, Gen. Counsel &Secretary | Sell | 18,625 | $126.96 | $2,364,670.98 | -43.3% | |
| Aug 5, 2016 | LGND Ligand Pharmaceuticals Inc | VP, Gen. Counsel &Secretary | Sale+OE | 22,067 | $123.16 | $2,717,771.72 | -19.9% | |
| Jul 10, 2015 | LGND Ligand Pharmaceuticals Inc | VP, Gen. Counsel &Secretary | Sale+OE | 14,067 | $99.14 | $1,394,609.94 | -13.0% | |
| Mar 16, 2015 | LGND Ligand Pharmaceuticals Inc | VP, Gen. Counsel &Secretary | Sale+OE | 11,264 | $74.54 | $839,649.12 | -12.6% |